S. Korea Group Urges Harder Look At IPA-Containing Painkillers
This article was originally published in PharmAsia News
Executive Summary
South Korea should take greater steps to ensure the safety of painkillers with isopropylantipyrine, according to the Korean Society for Pharmacoepidemiology and Risk Management. The group said the the drugs caused at least six cases of side effects as far back as 2002, and it counted six more recent cases of side effects that should have highlighted the risks. The Korean Food and Drug Administration identified three more cases in early December. IPA-containing painkillers are made in South Korea by Chong Kun Dang, Samjin Pharm, Dong-A Pharmaceutical and Bayer Korea. Chief side effects are cardiovascular disorders, spasms and unconsciousness. (Click here for more
You may also be interested in...
Bayer’s Saridon-A Among 28 Painkillers Banned To Those Under 15 In Korea
SEOUL - Amid rising claims that it isn't moving fast enough to counter public concern over the safety of OTC painkillers, Korea FDA has banned Bayer Korea's painkiller Saridon-A, Samjin Pharm's Geworin and 26 other products from being prescribed or sold over the counter to those under 15 years of age
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.